Marfan syndrome (MFS) is a rare inherited autosomic disorder, which encompasses a variety of systemic manifestations caused by mutations in the Fibrillin-1 encoding gene (FBN1). Cardinal clinical phenotypes of MFS are highly variable in terms of severity, and commonly involve cardiovascular, ocular, and musculoskeletal systems with a wide range of manifestations, such as ascending aorta aneurysms and dissection, mitral valve prolapse, ectopia lentis and long bone overgrowth, respectively. Of note, an accurate and prompt diagnosis is pivotal in order to provide the best treatment to the patients as early as possible. To date, the diagnosis of the syndrome has relied upon a systemic score calculation as well as DNA mutation identification. The aim of this review is to summarize the latest MFS evidence regarding the definition, differences and similarities with other connective tissue pathologies with severe systemic phenotypes (e.g., Autosomal dominant Weill–Marchesani syndrome, Loeys–Dietz syndrome, Ehlers–Danlos syndrome) and clinical assessment. In this regard, the management of MFS requires a multidisciplinary team in order to accurately control the evolution of the most severe and potentially life-threatening complications. Based on recent findings in the literature and our clinical experience, we propose a multidisciplinary approach involving specialists in different clinical fields (i.e., cardiologists, surgeons, ophthalmologists, orthopedics, pneumologists, neurologists, endocrinologists, geneticists, and psychologists) to comprehensively characterize, treat, and manage MFS patients with a personalized medicine approach.

Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies / S. Marelli, E. Micaglio, J. Taurino, P. Salvi, E. Rurali, G.L. Perrucci, C. Dolci, N. Samali Udugampolage, R. Caruso, D. Gentilini, G. Trifiro’, E. Callus, A. Frigiola, C. De Vincentiis, C. Pappone, G. Parati, A. Pini. - In: DIAGNOSTICS. - ISSN 2075-4418. - 13:13(2023 Jul 05), pp. 2284.1-2284.28. [10.3390/diagnostics13132284]

Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies

C. Dolci;R. Caruso
Writing – Review & Editing
;
E. Callus
Writing – Review & Editing
;
2023

Abstract

Marfan syndrome (MFS) is a rare inherited autosomic disorder, which encompasses a variety of systemic manifestations caused by mutations in the Fibrillin-1 encoding gene (FBN1). Cardinal clinical phenotypes of MFS are highly variable in terms of severity, and commonly involve cardiovascular, ocular, and musculoskeletal systems with a wide range of manifestations, such as ascending aorta aneurysms and dissection, mitral valve prolapse, ectopia lentis and long bone overgrowth, respectively. Of note, an accurate and prompt diagnosis is pivotal in order to provide the best treatment to the patients as early as possible. To date, the diagnosis of the syndrome has relied upon a systemic score calculation as well as DNA mutation identification. The aim of this review is to summarize the latest MFS evidence regarding the definition, differences and similarities with other connective tissue pathologies with severe systemic phenotypes (e.g., Autosomal dominant Weill–Marchesani syndrome, Loeys–Dietz syndrome, Ehlers–Danlos syndrome) and clinical assessment. In this regard, the management of MFS requires a multidisciplinary team in order to accurately control the evolution of the most severe and potentially life-threatening complications. Based on recent findings in the literature and our clinical experience, we propose a multidisciplinary approach involving specialists in different clinical fields (i.e., cardiologists, surgeons, ophthalmologists, orthopedics, pneumologists, neurologists, endocrinologists, geneticists, and psychologists) to comprehensively characterize, treat, and manage MFS patients with a personalized medicine approach.
Marfan syndrome; connective tissue disease; multidisciplinary approach; personalized medicine; Fibrillin-1;
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Settore BIO/16 - Anatomia Umana
Settore MED/03 - Genetica Medica
Settore MED/22 - Chirurgia Vascolare
Settore MED/45 - Scienze Infermieristiche Generali, Cliniche e Pediatriche
Settore MED/23 - Chirurgia Cardiaca
Settore M-PSI/08 - Psicologia Clinica
5-lug-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
diagnostics-13-02284.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 423.49 kB
Formato Adobe PDF
423.49 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/983728
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact